A double‐blind randomized, multicenter, placebo‐controlled study of itopride in functional dyspepsia postprandial distress syndrome

Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study

(2020) Ami D. Sperber et al.   GASTROENTEROLOGY

Influence of itopride and domperidone on gastric tone and on the perception of gastric distention in healthy subjects

(2019) Karen Van den Houte et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Analysis of Postprandial Symptom Patterns in Subgroups of Patients With Rome III or Rome IV Functional Dyspepsia

(2019) F. Carbone et al.   Clinical Gastroenterology and Hepatology

The effect of rikkunshito on gastrointestinal symptoms and gastric motor function: The first study in a Belgian functional dyspepsia population

(2019) Imke Masuy et al.   NEUROGASTROENTEROLOGY AND MOTILITY

The Waiting Room Questionnaire: Validation of a Novel Patient Reported Outcome Questionnaire for the Diagnosis of Functional Gastrointestinal Disorders

(2017) Nick Goelen et al.   GASTROENTEROLOGY

Analysis of Postprandial Symptom Patterns in Rome III and Rome IV Subgroups of Functional Dyspepsia Patients

(2017) Florencia Carbone et al.   GASTROENTEROLOGY

What's new in Rome IV?

(2017) J. Tack et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Validation of the Leuven Postprandial Distress Scale, a questionnaire for symptom assessment in the functional dyspepsia/postprandial distress syndrome

(2016) F. Carbone et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV

(2016) Douglas A. Drossman   GASTROENTEROLOGY

Gastroduodenal Disorders

(2016) Vincenzo Stanghellini et al.   GASTROENTEROLOGY

Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap

(2015) F. Carbone et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Functional dyspepsia: outcome of focus groups for the development of a questionnaire for symptom assessment in patients suffering from postprandial distress syndrome (PDS)

(2014) F. Carbone et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Functional dyspepsia: the economic impact to patients

(2013) B. E. Lacy et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Functional dyspepsia—symptoms, definitions and validity of the Rome III criteria

(2013) Jan Tack et al.   Nature Reviews Gastroenterology & Hepatology

Itopride therapy for functional dyspepsia: A meta-analysis

(2013) Xuan Huang   WORLD JOURNAL OF GASTROENTEROLOGY

Functional dyspepsia impairs quality of life in the adult population

(2011) P. Aro et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man

(2010) E. Scarpellini et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Minimum Clinically Important Difference for the Nepean Dyspepsia Index, a Validated Quality of Life Scale for Functional Dyspepsia

(2009) Michael Jones et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Functional Dyspepsia

(2009) Lieke A. S. van Kerkhoven et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings

(2009) h. piessevaux et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Prokinetics and fundic relaxants in upper functional GI disorders

(2008) J TACK   CURRENT OPINION IN PHARMACOLOGY

Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

(2007) N J Talley et al.   GUT